Special Issue "State-of-the-Art Molecular Oncology in UK"
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: closed (31 October 2022) | Viewed by 5363
Special Issue Editors

2. Medway NHS Foundation Trust, Windmill Road, Gillingham, Kent ME7 5NY, UK
3. Kent Medway Medical School, University of Kent, CT2 7LX, Canterbury, Kent, UK
4. AELIA Organization, 9(th)Km Thessaloniki-Thermi, 57001 Thessaloniki, Greece
Interests: ovarian cancer; cervical cancer; carcinoma of unknown primary; prostate cancer, renal cancer, colorectal cancer; cancer in pregnancy
Special Issues, Collections and Topics in MDPI journals
Interests: cancer genetics; biomarkers; SABR; brachytherapy
Special Issue Information
Dear Colleagues,
The basic research is focused on understanding the molecular mechanisms that govern cancer cell metastasis and treatment resistance. The improvement of our knowledge of the molecular mechanisms by defining pathways that influence cancer therapy and by developing new tools and therapeutics to prevent and treat effectively cancer is an ongoing effort. In the past few decades, oncological studies are evolving from traditional to Molecular Oncology.
Molecular Oncology is a rapidly growing field with a massive impact on basic science, medical application, and translational cancer research. Through the use of cutting edge technologies, Molecular Oncology aims to identify genes involved in the development of cancer. Researchers combine diverse techniques, ranging from genomics, computational biology, tumour imaging, in vitro and in vivo functional models, to study biological phenotypes. The proteins produced by these genes may serve as targets for novel therapeutic agents, or imaging scans. Molecular Oncology uses these combined techniques to validate the role of the novel candidate genes in the development of cancer.
This Topical Collection will bring together original research and review articles on Molecular Oncology, acknowledging the significant involvement scientists from the United Kingdom made to the research community in the Molecular Oncology field. The main feature of this Topical Collection is to provide an open-source sharing of significant works in the field of Molecular Oncology that can advance our understanding of carcinogenesis, novel molecular diagnostic technologies and targeted therapeutics. Special interest falls on novel mechanistic insights into cancer molecular pathways. The broad cancer community will have a forum for the publication of new discoveries, approaches, as well as state‐of‐the‐art technical developments, in basic and discovery‐driven translational cancer research.
Dr. Stergios Boussios
Dr. Christos Mikropoulos
Collection Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- DNA repair and genomic instability
- tumour immunology and immune response
- emerging technologies
- cancer genetics and epigenetics
- translational research
- integration of basic science into medical trials
- molecular pathology
- cancer microenvironment